1. Julian DG, Valentine PA, Miller GG. Disturbances of rate, rhythm and conduction in acute myocardial infarction. Am J Med37:915-921, 1964
2.
2. Scott DB, Julian JD (eds): Lidocaine in the Treatment of Ventricular Arrhythmias. Proceedings of a Symposium held in Edinburgh in September 1970. E&S Livingstone, Edinburgh and London, pp 1-240, 1970
4. Lown B, Wolf M.Approaches to sudden death from coronary artery disease. Circulation58:581-584, 1978
5.
5. Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. JAMA268:2171-2295, 1992
6.
6. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on morality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med321:406-410, 1989
7.
7. Furberg CD. Effect of anti-arrhythmic drugs on mortality after myocardial infarction. Am J Cardiol53:23C-36C, 1983
8.
8. Teo KK, Yusuf SS, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA270:1589-1595, 1993
9.
9. MacMahon S, Collins R, Perot R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction: An overview of results from randomized, controlled trials. JAMA260:1910-1916, 1988
10.
10. Hine LK, Laird N, Hewitt P, Chalmers TC. Meta-analytic evidence against prophylactic lidocaine in acute myocardial infarction. Arch Intern Med149:2694-2698, 1989
11.
11. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for the maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized control trials. Circulation82:1106-1116, 1990
12.
12. Singh BN, Vaughan Williams EM. Effects of altering potassium concentration on the action of lidocaine and diphenylhydantoin on rabbit atrial and ventricular muscle. Circ Res29:286-295, 1971
13.
13. Impact Research Group: International mexiletine and placebo antiarrhythmic coronary trial: Report on arrhythmias and other findings. J Am Coll Cardiol4:1148-1156, 1984
14.
14. Antman EM, Berlin JA. Declining incidence of ventricular fibrillation in myocardial infarction: Implications for the prophylactic use of lidocaine. Circulation86:764-770, 1992
15.
15. Singh BN. Routine prophylactic lidocaine administration in acute myocardial infarction. An idea whose time is all but gone?Circulation86:1033-1035, 1992
16.
16. Singh BN. Advantages of beta-blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction. Am J Cardiol66:9C-20C, 1989
17.
17. Hallstrom AP, Cobb LA, Yu BH, Weaver WD, Fahrenbruch CE. An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol68:1025-1031, 1991
18.
18. Boutitie F, Boisel JP, Connolly SJ, et al and the EMIAT and CAMIAT Investigators. Amiodarone interaction with betablockers: Analysis of the merged EMIAT and CAMIAT databases. Circulation99:2268-2275, 1999
19.
19. ISIS-1 Collaborative Group: Randomized trial on intravenous atenolol among 16,027 cases of suspected myocardial infarction. Lancet2:57-60, 1986
20.
20. Norris RM, Barnaby PF, Brown MA, et al. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet2:883-886, 1984
21.
21. Ryden L, Arciniego R, Amonan K.A double-blind trial of metoprolol in acute myocardial infarction: Effect of ventricular tachyarrhythmias. N Engl J Med308:614-618, 1983
22.
22. Teerlink JR, Massie BM. Beta-adrenergic blocker mortality trials in congestive heart failure. Am J Cardiol84:84R-102R, 1999
23.
23. Scheinman MM, Levine JG, Cannon DS, et al. Intravenous Amiodarone, Multicenter Investigators Group. Dose-ranging study of intravenous amiodarone in patients with lifethreatening ventricular tachyarrhythmias. Circulation92:3264-3272, 1995
24.
24. Levine JH, Massumi A, Scheinman MM, et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. J Am Coll Cardiol27:67-75, 1996
25.
25. Kowey PR, Levine JG, Herre JM, et al. Randomized double-blind comparison of intravenous amiodarone and bretylium, in the treatment of patients with recurrent hemodynamically destabilizing ventricular tachycardia or fibrillation. Circulation92:3255-3263, 1995
26.
26. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med341:871-878, 1999
27.
27. Dorian P, Cass D, Schwartz, Cooper R, Zelaznikas R, Barr A.Amiodarone as compared with lidocaine for shockresistant ventricular fibrillation. N Engl J Med346: 884-890, 2002
28.
28. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: An international consens on science. 6. Advanced cardiovascular life support. 5. Pharmacology 1: agents for arrhythmias. Circulation102(Suppl 1): 1-112-1-128, 2000
